Why the study?
Do cholesterol lowering treatments increase the risk of non-illness mortality (suicide, accident, or trauma) in patients undergoing primary or secondary prevention?
Population
19 large, randomised clinical trials of cholesterol lowering treatments (primary and secondary prevention)
Comparison
Cholesterol lowering treatments including… vs Control groups
Design
Meta-analysis
Follow-up
1-10 years
Authors
Loading...
No increased non-illness mortality with cholesterol-lowering therapy; confirms safety in primary and secondary prevention trials.
Do cholesterol lowering treatments increase the risk of non-illness mortality (suicide, accident, or trauma) in patients undergoing primary or secondary prevention?
Cholesterol-lowering treatments, particularly statins, do not significantly increase the risk of non-illness mortality such as suicide or accidents.
Matthew F. Muldoon (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: